Sign In
Buy TGT
$147.72
-0.370 (-0.250%)
At Close: Aug 05, 2026
OneWater Marine Inc. (NASDAQ:ONEW) Receives $20.00 Average Price Target from Analysts
01:58am, Friday, 24'th Oct 2025
Shares of OneWater Marine Inc. (NASDAQ: ONEW - Get Free Report) have earned a consensus rating of "Hold" from the nine ratings firms that are covering the firm, Marketbeat.com reports. One research an
Analysts Set MASTERCRAFT BOAT HOLDINGS, INC. (NASDAQ:MCFT) Price Target at $22.20
01:58am, Friday, 24'th Oct 2025
MASTERCRAFT BOAT HOLDINGS, INC. (NASDAQ: MCFT - Get Free Report) has received a consensus rating of "Hold" from the seven brokerages that are covering the company, Marketbeat reports. Six research ana
Target's new CEO cuts 1,800 jobs, the first in a decade, to tackle ‘complexity'
01:25am, Friday, 24'th Oct 2025
The US retail giant Target announced on Thursday that it is cutting 1,800 corporate jobs, a significant and painful restructuring that marks the company's first major round of layoffs in a decade.
Target to Cut 1,800 Corporate Jobs as It Struggles to Regain Momentum
07:02pm, Thursday, 23'rd Oct 2025
Target Corp. said on Thursday (Oct. 23) that it will eliminate 1,800 corporate roles, or 8% of its headquarters workforce, in its largest restructuring in years, a move designed to streamline operatio
Target to layoff 1,000 and cut hundreds of open roles ahead of new CEO starting job
06:02pm, Thursday, 23'rd Oct 2025
Target is cutting about 1,000 corporate positions and eliminating 800 open roles in an effort to speed up business decision-making and drive growth under its new chief executive, Michael Fiddelke.
Target plans to cut jobs as incoming CEO tries to fix ‘complexity': report
06:01pm, Thursday, 23'rd Oct 2025
As Target prepares for a new era with Michael Fiddelke at the helm, the retailer is reportedly cutting jobs in an effort to reduce the “complexity” that its new CEO says slowed down the company.
Trump Says US Will Target Drugs Coming In By Land
05:01pm, Thursday, 23'rd Oct 2025
President Donald Trump says the US will now heavily target drugs being brought into the US over land. The US has recently been targeting boats carrying drugs off the coast of Venezuela.
Target Plans to Lay Off Around 1,000 Employees
04:45pm, Thursday, 23'rd Oct 2025
The move is part of incoming CEO Michael Fiddelke's efforts to revitalize the ailing retailer.
Target is laying off about 1,000 corporate employees and cutting another 800 open roles
04:38pm, Thursday, 23'rd Oct 2025
Target is laying off around 1,000 corporate employees and cutting another 800 open roles, the company said Thursday. This story is breaking.
Target cuts 1,000 jobs, eliminates hundreds of open roles
04:36pm, Thursday, 23'rd Oct 2025
Incoming CEO Michael Fiddelke leads Target's restructuring effort to reduce complexity and speed decision-making, cutting 8% of global headquarters team positions.
Norfolk Southern Third-Quarter Sales Rise, Ups Productivity Target
04:34pm, Thursday, 23'rd Oct 2025
The railroad company, which agreed to sell itself to Union Pacific in July, reported a profit of $711 million and upped its productivity target to $200 million.
Target plans to lay off 1,800 employees, WSJ reports
04:25pm, Thursday, 23'rd Oct 2025
Target plans to lay off around 1,800 employees as part of its strategy to reverse stagnant sales, the Wall Street Journal reported on Thursday, citing people familiar with the matter.
Target cuts 1,800 corporate jobs in its first major layoffs in a decade
04:12pm, Thursday, 23'rd Oct 2025
Target said Thursday that it's cutting 1,800 roles across the company, or roughly 8% of its corporate workforce. It marks the largest round of layoffs at the company in a decade.
Trump Sanctions Aim at Russian Oil, but the Real Target Might Be Elsewhere
01:23pm, Thursday, 23'rd Oct 2025
The U.S. is seeking leverage in its trade negotiations with China.
Viking Therapeutics: The Prime Target In The Obesity Gold Rush
10:05am, Thursday, 23'rd Oct 2025
Viking Therapeutics, Inc. is a clinical-stage biotech focused on metabolic and endocrine therapies, highlighted by its promising VK2735 obesity drug. VKTX's pipeline includes late-stage GLP-1/GIP agon
